US Broker Ratings

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 102.81% Upside in the Medical Devices Sector

Beta Bionics, Inc. (BBNX) is making waves in the healthcare sector, specifically within the medical devices industry. Headquartered in Irvine, California, this innovative company has gained attention for its cutting-edge..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 43.53% Potential Upside for Investors

HealthStream, Inc. (NASDAQ: HSTM), a vital player in the burgeoning Health Information Services industry, presents a potentially lucrative opportunity for investors seeking exposure to the healthcare sector. With a market..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring 59% Potential Upside and Promising Cancer Therapies

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is turning heads in the biotechnology sector with its promising pipeline of cancer therapies. Despite the current market pressures, Arcus presents..

Enliven Therapeutics (ELVN) Stock Analysis: A Biotech Contender with 18% Upside Potential

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a trailblazer in the biotechnology sector, has been catching the eye of investors with its promising innovations and a significant potential upside of 18.17%. Headquartered..

Oculis Holding AG (OCS) Stock Analysis: Eye-Catching 87% Potential Upside Amid Robust Revenue Growth

Oculis Holding AG (NASDAQ: OCS), a Swiss biopharmaceutical company, is grabbing investor attention with its notable 87.44% potential upside, as suggested by analysts’ average target price. Specializing in developing innovative..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a Potential 93% Upside

Weave Communications, Inc. (NASDAQ: WEAV) presents a compelling opportunity for investors seeking growth potential in the healthcare sector, particularly in health information services. With a market capitalization of $355.49 million,..

Zymeworks Inc. (ZYME) Investor Outlook: A 62% Potential Upside Amid Robust Analyst Confidence

For investors keen on exploring growth opportunities within the biotechnology sector, Zymeworks Inc. (NASDAQ: ZYME) presents an intriguing proposition. The company, which is based in the United States, operates within..

Geron Corporation (GERN) Stock Analysis: Exploring a 120% Upside Potential in Biotech

Geron Corporation (NASDAQ: GERN), a prominent player in the biotechnology sector, has been gaining attention from investors due to its promising product pipeline and the potential for significant upside in..

uniQure N.V. (QURE) Stock Analysis: Exploring a Potential 141% Upside in Gene Therapy Innovation

uniQure N.V. (NASDAQ: QURE), a pioneering company in the biotechnology sector, continues to capture investor attention with its innovative approach to addressing rare and devastating diseases. Headquartered in Amsterdam, Netherlands,..

Nutex Health Inc. (NUTX) Stock Analysis: Uncovering a Potential 133.68% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might want to turn their attention to Nutex Health Inc. (NUTX), a company that operates an intriguing business model within the medical care..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 20.9% Revenue Surge in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing for animal health. With a market capitalization..

CorMedix Inc. (CRMD) Stock Analysis: A Potential 117% Upside in the Biotech Sector

CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company based in Parsippany, New Jersey, is making waves in the healthcare sector with a compelling growth narrative. Specializing in therapeutic products targeting life-threatening..

Spyre Therapeutics, Inc. (SYRE) Investor Outlook: Strong Buy Ratings Signal Potential 28% Upside

Spyre Therapeutics, Inc. (SYRE) is a name that individual investors should keep a close eye on, especially given its impressive potential upside of 27.92% based on current analyst ratings. This..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: 165% Potential Upside in the Biotech Arena

Gyre Therapeutics, Inc. (GYRE) has emerged as a compelling opportunity in the biotechnology sector, particularly for investors with an appetite for growth and innovation in healthcare. Based out of San..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unveiling a 90% Upside Potential in Gene Editing Innovation

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the biotechnology sector, garnering significant attention from investors intrigued by its innovative approach to gene editing. As a clinical-stage company,..

Workday, Inc. (WDAY) Stock Analysis: Unveiling a 42.68% Potential Upside for Investors

Amidst the challenging landscape of the technology sector, Workday, Inc. (NASDAQ: WDAY) emerges as a compelling prospect for investors, boasting a notable potential upside of 42.68%. As a leader in..

Paylocity Holding Corporation (PCTY) Stock Analysis: Uncovering a 54.59% Potential Upside Amidst Robust Revenue Growth

For investors eyeing the technology sector, Paylocity Holding Corporation (NASDAQ: PCTY) offers a compelling opportunity with a significant upside potential. As a key player in the software application industry, Paylocity..

Q2 Holdings, Inc. (QTWO) Stock Analysis: Unpacking a 65% Potential Upside for Investors

Q2 Holdings, Inc. (NASDAQ: QTWO), a leading player in the technology sector with a focus on application software, has been capturing investor attention due to its robust growth potential and..

Diebold Nixdorf (DBD) Investor Outlook: 21.82% Potential Upside in the Software Application Sector

Diebold Nixdorf Incorporated (NYSE: DBD), a prominent player in the technology sector specializing in software applications, presents an intriguing opportunity for investors seeking growth in the financial automation and retail..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds